跳至主導覽 跳至搜尋 跳過主要內容

Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system

  • Ardalan Ebrahimi*
  • , Ziv Gil
  • , Moran Amit
  • , Tzu Chen Yen
  • , Chun Ta Liao
  • , Pankaj Chatturvedi
  • , Jaiprakash Agarwal
  • , Luiz Kowalski
  • , Matthias Kreppel
  • , Claudio Cernea
  • , Jose Brandao
  • , Gideon Bachar
  • , Andrea Bolzoni Villaret
  • , Dan Fliss
  • , Eran Fridman
  • , K. Thomas Robbins
  • , Jatin Shah
  • , Snehal Patel
  • , Jonathan Clark
  • *此作品的通信作者
  • Royal Prince Alfred Hospital
  • Western Sydney University
  • University of New South Wales
  • Technion-Israel Institute of Technology
  • Chang Gung Memorial Hospital
  • Tata Memorial Hospital
  • A.C.Camargo Cancer Center
  • University of Cologne
  • Universidade de São Paulo
  • Rabin Medical Center Israel
  • University of Brescia
  • Tel Aviv Sourasky Medical Center
  • Southern Illinois University
  • Memorial Sloan-Kettering Cancer Center

研究成果: 期刊稿件 › 文章 › 同行評審

20 引文 斯高帕斯(Scopus)

摘要

Background We hypothesized that pathological N1 (pN1) and N2a (pN2a) nodal disease portend a similar prognosis in patients with oral cancer. Methods An international multicenter study of 739 oral squamous cell carcinoma (SCC) patients with pN1 or pN2a stage disease was conducted. Multivariable analyses were performed using Cox proportional hazard models to compare locoregional failure, disease-specific survival (DSS), and overall survival (OS). Institutional heterogeneity was assessed using 2-stage random effects meta-analysis techniques. Results Univariate analysis revealed no difference in locoregional failure (p =.184), DSS (p =.761), or OS (p =.475). Similar results were obtained in adjusted multivariable models and no evidence of institutional heterogeneity was demonstrated. Conclusion The prognosis of pN2a and pN1 disease is similar in oral SCC suggesting these categories could be combined in future revisions of the nodal staging system to enhance prognostic accuracy. However, these results may reflect more aggressive treatment of N2a disease; hence, we caution against using these data to deintensify treatment.

原文英語
頁(從 - 到)135-139
頁數5
期刊Head and Neck
卷38
發行號1
DOIs
出版狀態已出版 - 01 01 2016
對外發佈是

文獻附註

Publisher Copyright:
© 2015 Wiley Periodicals, Inc.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system」主題。共同形成了獨特的指紋。

引用此